New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Modern lifestyle heart disease risk factors threaten extremely poor people in low- and middle-income countries

Modern lifestyle heart disease risk factors threaten extremely poor people in low- and middle-income countries

by University of BirminghamCredit: Pixabay/CC0 Public DomainA new study reveals that many people living in extreme poverty in low- and middle-income countries (LMICs) have conditions that lead to
Cardiovascular Diseases March 20,2024
Modern lifestyle heart disease risk factors threaten extremely poor people in low- and middle-income countries

Modern lifestyle heart disease risk factors threaten extremely poor people in low- and middle-income countries

by University of BirminghamCredit: Pixabay/CC0 Public DomainA new study reveals that many people living in extreme poverty in low- and middle-income countries (LMICs) have conditions that lead to
Cardiovascular Diseases March 20,2024
COVID jab linked to lower risk of COVID-19–related clot and heart complications

COVID jab linked to lower risk of COVID-19–related clot and heart complications

by University of OxfordForest plots for the effect of COVID-19 vaccines on post-COVID-19 cardiac and thromboembolic complications; meta-analysis across cohorts and databases. Credit:Heart&n
Cardiovascular Diseases March 20,2024
COVID jab linked to lower risk of COVID-19–related clot and heart complications

COVID jab linked to lower risk of COVID-19–related clot and heart complications

by University of OxfordForest plots for the effect of COVID-19 vaccines on post-COVID-19 cardiac and thromboembolic complications; meta-analysis across cohorts and databases. Credit:Heart&n
Cardiovascular Diseases March 20,2024
Paclitaxel-coated balloon effective for coronary in-stent restenosis: Study

Paclitaxel-coated balloon effective for coronary in-stent restenosis: Study

by Elana GotkineA paclitaxel-coated balloon is superior to an uncoated balloon for the composite end point of target lesion failure among patients undergoing coronary angioplasty for in-stent restenos
Cardiovascular Diseases March 20,2024
Paclitaxel-coated balloon effective for coronary in-stent restenosis: Study

Paclitaxel-coated balloon effective for coronary in-stent restenosis: Study

by Elana GotkineA paclitaxel-coated balloon is superior to an uncoated balloon for the composite end point of target lesion failure among patients undergoing coronary angioplasty for in-stent restenos
Cardiovascular Diseases March 20,2024
Prevalence of self-reported hypertension 30 percent in 2017 to 2021

Prevalence of self-reported hypertension 30 percent in 2017 to 2021

by Elana GotkineThe overall age-standardized prevalence of hypertension was about 30 percent in 2017 to 2021, according to researchpublishedin the March 7 issue of the U.S. Centers for Dis
Cardiovascular Diseases March 20,2024
Prevalence of self-reported hypertension 30 percent in 2017 to 2021

Prevalence of self-reported hypertension 30 percent in 2017 to 2021

by Elana GotkineThe overall age-standardized prevalence of hypertension was about 30 percent in 2017 to 2021, according to researchpublishedin the March 7 issue of the U.S. Centers for Dis
Cardiovascular Diseases March 20,2024
Under newly-revised guidelines, more stroke patients qualify for life-saving thrombectomy

Under newly-revised guidelines, more stroke patients qualify for life-saving thrombectomy

by Christopher DeFrancesco,University of ConnecticutCredit: Pixabay/CC0 Public DomainUConn Health has elite expertise in a highly specialized cranial procedure known to be effective as an urgent
Cardiovascular Diseases March 20,2024
Under newly-revised guidelines, more stroke patients qualify for life-saving thrombectomy

Under newly-revised guidelines, more stroke patients qualify for life-saving thrombectomy

by Christopher DeFrancesco,University of ConnecticutCredit: Pixabay/CC0 Public DomainUConn Health has elite expertise in a highly specialized cranial procedure known to be effective as an urgent
Cardiovascular Diseases March 20,2024
Blood pressure control in veterans declined during the COVID-19 pandemic

Blood pressure control in veterans declined during the COVID-19 pandemic

by Veterans Affairs Research CommunicationsCredit: Pavel Danilyuk from PexelsA multi-institution team led by researchers at the White River Junction VA Medical Center in Vermont found that Veterans&#3
Cardiovascular Diseases March 20,2024
Blood pressure control in veterans declined during the COVID-19 pandemic

Blood pressure control in veterans declined during the COVID-19 pandemic

by Veterans Affairs Research CommunicationsCredit: Pavel Danilyuk from PexelsA multi-institution team led by researchers at the White River Junction VA Medical Center in Vermont found that Veterans&#3
Cardiovascular Diseases March 20,2024
Novel risk score for cardiovascular complications after bone marrow transplant

Novel risk score for cardiovascular complications after bone marrow transplant

by Noah Fromson,University of Michigan3D Model of the heart by Dr. Matthew Bramlet. Credit: NIHFor thousands of Americans each year, a bone marrow transplant has the potential to cure diseases s
Cardiovascular Diseases March 20,2024
Novel risk score for cardiovascular complications after bone marrow transplant

Novel risk score for cardiovascular complications after bone marrow transplant

by Noah Fromson,University of Michigan3D Model of the heart by Dr. Matthew Bramlet. Credit: NIHFor thousands of Americans each year, a bone marrow transplant has the potential to cure diseases s
Cardiovascular Diseases March 20,2024
AI research gives unprecedented insight into heart genetics and structure

AI research gives unprecedented insight into heart genetics and structure

by Michael Addelman,University of ManchesterVariants in the TTN, PLN and STRN loci show distinct effects on LV morphology. a–c, Manhattan plots for LV latent variables with best association for
Cardiovascular Diseases March 20,2024
AI research gives unprecedented insight into heart genetics and structure

AI research gives unprecedented insight into heart genetics and structure

by Michael Addelman,University of ManchesterVariants in the TTN, PLN and STRN loci show distinct effects on LV morphology. a–c, Manhattan plots for LV latent variables with best association for
Cardiovascular Diseases March 20,2024
Tracking troponin I over time to manage blood pressure and predict risk of heart disease

Tracking troponin I over time to manage blood pressure and predict risk of heart disease

by Anna Jones,University of Alabama at BirminghamCredit: CC0 Public DomainCardiac troponins are a group of markers used to predict the risk of heart disease. However, it is not well understood h
Cardiovascular Diseases March 20,2024
Tracking troponin I over time to manage blood pressure and predict risk of heart disease

Tracking troponin I over time to manage blood pressure and predict risk of heart disease

by Anna Jones,University of Alabama at BirminghamCredit: CC0 Public DomainCardiac troponins are a group of markers used to predict the risk of heart disease. However, it is not well understood h
Cardiovascular Diseases March 20,2024
Race, racism and risk prediction for cardiovascular disease

Race, racism and risk prediction for cardiovascular disease

by Keith Churchwell and Sadiya S. Khan,American Heart AssociationCredit: Pixabay/CC0 Public DomainWhen clinicians are discussing long-term health with a patient, we often find ourselves struggli
Cardiovascular Diseases March 20,2024
Race, racism and risk prediction for cardiovascular disease

Race, racism and risk prediction for cardiovascular disease

by Keith Churchwell and Sadiya S. Khan,American Heart AssociationCredit: Pixabay/CC0 Public DomainWhen clinicians are discussing long-term health with a patient, we often find ourselves struggli
Cardiovascular Diseases March 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com